Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.57 |
| ▸ | GRPR | P30550 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | CCKAR | P32238 | 1/20 | 0.52 |
| ▸ | CCKBR | P32239 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29406603 | 0.97 | CTSB (0.54) | OPRM1OPRD1OPRK1CTSBCCKAR | |
| SCHEMBL2189862 | 0.92 | OPRM1 (0.55) | OPRM1OPRD1OPRK1GRPR | |
| SCHEMBL29678561 | 0.92 | CCKAR (0.51) | OPRM1OPRD1OPRK1CCKARCCKBR | |
| SCHEMBL31230203 | 0.90 | OPRM1 (0.60) | OPRM1OPRD1OPRK1CTSB | |
| SCHEMBL29678344 | 0.90 | NPY4R (0.56) | — | |
| Neurokinin B SCHEMBL29390479 | 0.87 | GRPR (0.59) | GRPR | |
| Neurokinin B SCHEMBL29440672 | 0.87 | GRPR (0.59) | GRPR | |
| Neurokinin B SCHEMBL29372314 | 0.87 | GRPR (0.53) | GRPRCCKARCCKBR | |
| SCHEMBL8019418 | 0.86 | OPRD1 (0.58) | OPRM1OPRD1OPRK1 | |
| SCHEMBL29973377 | 0.85 | OPRM1 (0.56) | OPRM1OPRD1OPRK1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3820563-B1 | STIMULATOR DEVICE FOR USE IN CONTROLLING WASTE STORAGE FOR A PATIENT | DIGNIFY THERAPEUTICS LLC (US) | 2025-10-01 | — | — | EP | disclosed |
| CN-118649241-B | Application of polypeptide chain, nano material, preparation method and application of nano material, and medicine for preventing and/or treating central precocity | 四川大学华西第二医院 | 2025-04-25 | — | — | CN | disclosed |
| CN-118649241-A | Application of polypeptide chain, nano material, preparation method and application of nano material, and medicine for preventing and/or treating central precocity | 四川大学华西第二医院 | 2024-09-17 | — | — | CN | disclosed |
| US-20230374071-A1 | COMPOSITIONS FOR INDUCING URINARY VOIDING AND DEFECATION | DIGNIFY THERAPEUTICS, LLC | 2023-11-23 | — | — | US | disclosed |
| EP-4225771-A1 | COMPOSITIONS FOR INDUCING URINARY VOIDING AND DEFECATION | Dignify Therapeutics, LLC (US) | 2023-08-16 | — | — | EP | disclosed |
| US-11584709-B2 | Multitarget drug for treating diseases in mammals | “PHARMENTERPRISES EURASIA” LIMITED LIABILITY COMPANY (RU) | 2023-02-21 | — | — | US | disclosed |
| US-11414377-B2 | Modulator of metabotropic and ionotropic transmembrane receptors and use thereof | IBD THERAPEUTICS LLC (RU) | 2022-08-16 | — | — | US | disclosed |
| US-11352391-B2 | Compositions for inducing urinary voiding and defecation | DIGNIFY THERAPEUTICS, LLC (US) | 2022-06-07 | — | — | US | disclosed |
| WO-2022076815-A1 | COMPOSITIONS FOR INDUCING URINARY VOIDING AND DEFECATION | DIGNIFY THERAPEUTICS, LLC (US) | 2022-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11414377-B2 | Modulator of metabotropic and ionotropic transmembrane receptors and use thereof | TRPM8, TRPV1, TRPA1 | OPRM1 31/4885OPRD1 53/4885OPRK1 24/4885 |
| US-20230374071-A1 | COMPOSITIONS FOR INDUCING URINARY VOIDING AND DEFECATION | VIP, VIPR1, VIPR2 | OPRM1 231/4885OPRD1 211/4885OPRK1 115/4885 |
| US-11584709-B2 | Multitarget drug for treating diseases in mammals | CTSB, CCKBR, BDKRB1 | OPRM1 240/4885OPRD1 249/4885OPRK1 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.